Janssen-Cilag Ltd

50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone: +44 (0)1494 567 567
Fax: +44 (0)1494 567 568
WWW: http://www.janssen.co.uk
WWW: http://www.janssen-medinfo.co.uk
Medical Information Direct Line: +44 (0)800 731 8450
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +44 (0)800 731 5550

Patient Information Leaflet last updated on the eMC: 15/08/2011
PIL Sporanox I.V. 10mg/ml concentrate and solvent for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 20/12/2010 and displayed until 15/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
  • Change to information about driving or using machinery
Updated on 22/10/2010 and displayed until 20/12/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 10/02/2010 and displayed until 22/10/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to storage instructions
Updated on 18/04/2009 and displayed until 10/02/2010
Reasons for adding or updating:
  • Change to Further Information section
Updated on 16/03/2009 and displayed until 18/04/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 18/09/2008 and displayed until 16/03/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 12/12/2007 and displayed until 18/09/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
Updated on 21/02/2007 and displayed until 12/12/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 25/01/2007 and displayed until 21/02/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to date of revision
Updated on 27/05/2005 and displayed until 25/01/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 25/05/2005 and displayed until 27/05/2005
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to packaging
  • Change to drug interactions
  • Change to side-effects
  • Change to date of revision
Updated on 03/09/2004 and displayed until 25/05/2005
Reasons for adding or updating:
  • Change of active ingredient
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to side-effects
  • Change to storage instructions
  • Change to information about pregnancy or lactation
  • Change to date of revision
  • Change to how to administer the medicine
Updated on 29/06/2004 and displayed until 03/09/2004
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 26/03/2002 and displayed until 29/06/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 21/02/2002 and displayed until 26/03/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 20/02/2002 and displayed until 21/02/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 09/04/2001 and displayed until 20/02/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   itraconazole trihydrochloride